[1]杨浩,舒强,郭晓东.婴幼儿血管瘤的治疗进展[J].临床小儿外科杂志,2019,18(08):640-645.[doi:10.3969/j.issn.1671-6353.2019.08.005]
　Yang Hao,Shu Qiang,Guo Xiaodong.Recent advances in the treatment of infantile hemangiomas[J].Journal of Clinical Pediatric Surgery,2019,18(08):640-645.[doi:10.3969/j.issn.1671-6353.2019.08.005]
点击复制

婴幼儿血管瘤的治疗进展

《临床小儿外科杂志》[ISSN:1671-6353/CN:43-1380/R] 卷: 第18卷 期数: 2019年08期 页码: 640-645 栏目: 专题·脉管异常类疾病 出版日期: 2019-08-25
Title:
Recent advances in the treatment of infantile hemangiomas
作者:
杨浩1;  舒强2;  郭晓东3
1. 浙江大学医学院儿科学(小儿外科)(浙江省杭州市, 310058);
2. 浙江大学医学院附属儿童医院(浙江省杭州市, 310052);
3. 浙江大学金华医院小儿外科(浙江省金华市, 321000)
Author(s):
Yang Hao1;  Shu Qiang2;  Guo Xiaodong3
1. Zhejiang University School of Medicine, Hangzhou 310058, China;
2. Children’s Hospital, Zhejiang University School of Medicine, Hangzhou, 310052, China;
3. Department of Pediatric Surgery, Jinhua Municipal Central Hospital, Jinhua 321000, China
关键词:
婴儿; 血管瘤/治疗; 激光; 药物/β受体阻滞剂; 外科手术
Keywords:
Infant; Hemangioma/TH; Lasers; Drug/Beta Receptor Blockers; Surgical Procedures; Operative
分类号:
R543;R732.2
DOI:
10.3969/j.issn.1671-6353.2019.08.005
摘要:
婴幼儿血管瘤（Infantile hemangiomas，IH）是婴幼儿最常见的良性肿瘤，瘤体在早期迅速增长，随后逐渐消退，消退后部分瘤体仍有残余。部分IH患儿可出现瘤体出血、溃疡、影响呼吸、视力或美观，甚至危及生命等，因此需积极干预。目前常规治疗IH的方法包括激光治疗、外用药物治疗、口服药物治疗、局部注射治疗、手术切除等。本文旨在对上述治疗婴幼儿血管瘤的方法及进展予以综述。
Abstract:
As one of the most common benign tumors during early infancy,infantile hemangiomas (IH) tend to undergo rapid growth followed by gradual involution.The complications of hemorrhage,ulceration,obstruction of airway,impairment of vision,disfigurement or even death require aggressive therapeutic interventions.Currently conventional treatments of IH include LASER,topical or oral medications,local injection therapy and surgical resection,etc.This article reviews the treatment options and recent advances of IH.

参考文献/References:

1 Munden A,Butschek R,Tom WL,et al.Prospective study of infantile haemangiomas:incidence,clinical characteristics and association with placental anomalies[J].Br J Dermatol,2014,170(4):907-913.DOI:10.1111/bjd.12804.
2 Guo S,Ni N.Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution[J].Arch Ophthalmol,2010,128(2):255-256.DOI:10.1001/archophthalmol.2009.370.
3 Borok J,Gangar P,Admani S,et al.Safety and efficacy of topical timolol treatment of infantile haemangioma:a prospective trial[J].Br J Dermatol,2018,178(1):e51-e52.DOI:10.1111/bjd.15865.
4 Droitcourt C,Kerbrat S,Rault C,et al.Safety of oral propranolol for infantile hemangioma[J].Pediatrics,2018,141(6):e20173783.DOI:10.1542/peds.2017-3783.
5 Ge J,Zheng J,Zhang L,et al.Oral propranolol combined with topical timolol for compound infantile hemangiomas:a retrospective study[J].Sci Rep,2016,6:19765.DOI:10.1038/srep19765.
6 Puttgen K,Lucky A,Adams D,et al.Topical timolol maleate treatment of infantile hemangiomas[J].Pediatrics,2016,138(3):e20160355.DOI:10.1542/peds.2016-0355.
7 Zheng L,Li Y.Effect of topical timolol on response rate and adverse events in infantile hemangioma:a meta-analysis[J].Arc Dermatol Res,2018,310(4):261-269.DOI:10.1007/s00403-018-1815-y.
8 王俞明,耿峰,查宗煜,等.0.5%噻吗洛尔溶液局部治疗婴幼儿血管瘤的疗效观察[J].组织工程与重建外科杂志,2012,8(04):208-212.DOI:10.3969/j.issn.1673-0364.2012.04.007.Wang YM,Geng F,Zha ZY,et al.Effectiveness of 0.5% solution of topical timolol maleate for infantile hemangiomas[J].Journal of Tissue Engineering & Reconstructive Surgery,2012,8(04):208-212.DOI:10.3969/j.issn.1673-0364.2012.04.007.
9 Frommelt P,Juern A,Siegel D,et al.Adverse events in young and preterm infants receiving topical timolol for infantile hemangioma[J].Pediatr Dermatol,2016,33(4):405-414.DOI:10.1111/pde.12869.
10 Rocco R,Alegre N,Pozner R,et al.Selective hemangioma cell dysfunction and apoptosis triggered by in vitro,treatment with imiquimod[J].Toxicol Lett,2018,288:82-88.DOI:10.1016/j.toxlet.2018.01.016.
11 Hu L,Huang HZ,Li X,et al.Open-label nonrandomized left-right comparison of imiquimod 5% ointment and timolol maleate 0.5% eye drops in the treatment of proliferating superficial infantile hemangioma[J].Dermatology,2015,230(2):150-155.DOI:10.1159/000369164.
12 Nguyen J,Fay A.Pharmacologic therapy for periocular infantile hemangiomas:a review of the literature[J].Semin Ophthalmol,2009,24(3):178-184.DOI:10.1080/08820530902805602.
13 Couto JA,Greene AK.Management of problematic infantile hemangioma using intralesional triamcinolone:efficacy and safety in 100 infants[J].J Plast Reconstr Aesthet Surg,2014,67(11):1469-1474.DOI:10.1016/j.bjps.2014.07.009.
14 杨耀武,郑家伟,孙沫逸,等.聚桂醇硬化剂治疗口腔颌面部血管瘤和脉管畸形专家共识[J].中国口腔颌面外科杂志,2018,16(3):275-278.DOI:10.19438/j.cjoms.2018.03.017.Yang YW,Zheng JW,Sun YM,et al.Expert consensus on the treatment of oral and maxillofacial hemangiomas and vascular malformations by lauromacrogol sclerotherapy[J].China Journal of oral and Maxillofac Surgery,2018,16(3):275-278.DOI:0.19438/j.cjoms.2018.03.017.
15 蔡仁慧,吕萍.聚桂醇泡沫硬化剂治疗婴幼儿血管瘤79例临床观察[J].中国皮肤性病学杂志,2017,31(7):740-742.DOI:10.13735/j.cjdv.1001-7089.201701035.Cai RH,Lv P.Efficacy of lauromacrogol foam sclerotherapy in the treatment of 79 cases of infantile hemangioma[J].Chin J Derm Venereol,2017,31(7):740-742.DOI:10.13735/j.cjdv.1001-7089.201701035.
16 Gao Z,Zhang Y,Li W,et al.Effectiveness and safety of polidocanol for the treatment of hemangiomas and vascular malformations:a meta-analysis[J].Dermatol Ther,2017,31(1):e12568.DOI:10.1111/dth.12568.
17 Qiu Y,Lin X,Ma G,et al.Eighteen cases of soft tissue atrophy after intralesional bleomycin a5 injections for the treatment of infantile hemangiomas:a long-term follow-up[J].Pediatr Dermatolo,2015,32(2):188-191.DOI:10.1111/pde.12422.
18 Pandey V,Tiwari P,Sharma SP,et al.Role of intralesional bleomycin and intralesional triamcinolone therapy in residual haemangioma following propranolol[J].Int J Oral Maxillofac Surg,2018,47(7):908-912.DOI:10.1016/j.ijom.2018.03.024.
19 董娟,纪尧峰.超声引导下射频消融治疗婴幼儿腮腺血管瘤[J].临床小儿外科杂志,2014,13(6):555-556.DOI:10.3969/j.issn.1671-6353.2014.06.027.Dong J,Ji YF.Ultrasound-guided RFA for the treatment of parotid gland hemangioma in infants[J].J Clin Ped Sur,2014,13(6):555-556.DOI:10.3969/j.issn.1671-6353.2014.06.027.
20 向芳,丁媛,于世荣.595 nm脉冲染料激光治疗婴幼儿皮肤真性血管瘤疗效观察[J].实用皮肤病学杂志,2014,7(4):291-293.DOI:10.11786/sypfbxzz.1674-1293.20140418.Xiang F,Ding Y,Yu SR.Curative effect analysis of 595 nm pulsed dye laser in the treatment of infantile hemangioma[J].Journal of Practical Dermatology,2014,7(4):291-293.DOI:10.11786/sypfbxzz.1674-1293.20140418.
21 Chinnadurai S,Sathe NA,Surawicz T.Laser treatment of infantile hemangioma:A systematic review[J].Lasers Surg Med,2016,48(3):221-233.DOI:10.1002/lsm.22455.
22 Li DN,Gold MH,Sun ZS,et al.Treatment of infantile hemangioma with optimal pulse technology[J].J Cosmet Laser Ther,2010,12(3):145-150.DOI:10.3109/14764172.2010.487908.
23 Zhong SX,Tao YC,Zhou JF,et al.Infantile Hemangioma:Clinical characteristics and efficacy of treatment with the long-pulsed 1,064-nm neodymium-doped yttrium aluminum garnet Laser in 794 Chinese patients[J].Pediatr Dermatol,2015,32(4):495-500.DOI:10.1111/pde.12593.
24 Stier MF,Glick SA,Hirsch RJ.Laser treatment of pediatric vascular lesions:Port wine stains and hemangiomas[J].J Am Acad Dermato,2008,58(2):261-285.DOI:10.1016/j.jaad.2007.10.492.
25 Ali A,Aiman U,Haseen MA,et al.The effect of oral propranolol versus oral corticosteroids in management of pediatric hemangiomas[J].World J Plast Surg,2018,7(1):16-24.
26 Greene AK,Couto RA.Oral prednisolone for infantile hemangioma:efficacy and safety using a standardized treatment protocol[J].Plast Reconstr Surg,2011,128(3):743-752.DOI:10.1097/PRS.0b013e3182221398.
27 Laken PA.Infantile hemangiomas:pathogenesis and review of propranolol use[J].Adv Neonatal Care,2016,16(2):135-142.DOI:10.1097/ANC.0000000000000254.
28 Liu X,Qu X,Zheng J,et al.Effectiveness and safety of oral propranolol versus other treatments for infantile hemangiomas:a meta-analysis[J].Plos One,2015,10(9):e0138100.DOI:10.1371/journal.pone.0138100.
29 Krowchuk DP,Frieden IJ,Mancini AJ,et al.Clinical Practice Guideline for the Management of Infantile Hemangiomas[J].Pediatr,2019,143(1):e20183475.DOI:10.1542/peds.2018-3475.
30 Oksiuta M,Matuszczak E,Debek W,et al.Treatment of problematic infantile hemangiomas with propranolol:a series of 40 cases and review of the literature[J].Postepy Hig Med Dosw,2014,68:1138-1344.DOI:10.5604/17322693.1120990.
31 Gonzalez-Llorente N,Del OI,Munoz-Ollero N,et al.Study of cognitive function in children treated with propranolol for infantile hemangioma[J].Pediatr Dermatol,2017,34(5):554-558.DOI:10.1111/pde.13229.
32 Hoeger PH,Harper JI,Baselga E,et al.Treatment of infantile haemangiomas:recommendations of a European expert group[J].Eur J Pediatr,2015,174(7):855-865.DOI:10.1007/s00431-015-2570-0.
33 郑家伟,杨秀娟.血管瘤的治疗选择[J].中国实用口腔科杂志,2009,2(5):274-279.DOI:10.3969/j.issn.1674-1595.2009.05.006.Zheng JW,Yang XJ.Selection of treatment modalities for infantile hemangiomas[J].Chinese Journal of Practical Stomatology,2009,2(5):274-279.DOI:10.3969/j.issn.1674-1595.2009.05.006.
34 李田园,贾仁兵,范先群.婴幼儿眼部血管瘤的治疗进展[J].临床眼科杂志,2017,25(6):560-564.DOI:10.3969/j.issn.1006-8422.2017.06.024.Li TY,Jia RB,Fan XQ.Advances in the treatment of periorbital infantile hemangiomas[J].Journal of Clinical Ophthalmology,2017,25(6):560-564.DOI:10.3969/j.issn.1006-8422.2017.06.024.
35 Tangtatco JA,Freedman C,Phillips J,et al.Surgical treatment outcomes of infantile hemangioma in children:does prior medical treatment matter[J].Pediatr Dermatol,2018,35(6):e418-e419.DOI:10.1111/pde.13658.
36 Lou H,Xu G,Huo R.Curative effect and safety of propranolol combined with prednisone in the treatment of infantile hemangiomas[J].Exp Ther Med,2018,15(6):4677-4682.DOI:10.3892/etm.2018.6035.
37 Li S,Xu G,Gao F,et al.Expression and association of VEGF-Notch pathways in infantile hemangiomas[J].Exp Ther Med,2017,14(4):3737-3743.DOI:10.3892/etm.2017.4943.
38 Bayart CB,Tamburro JE,Vidimos AT,et al.Atenolol versus propranolol for treatment of infantile hemangiomas during the proliferative phase:a retrospective noninferiority study[J].Pediatr Dermatol,2017,34(4):413-421.DOI:10.1111/pde.13177.

相似文献/References:

[1]宁岩松,张供.婴儿主动脉弓阻塞病变的外科治疗[J].临床小儿外科杂志,2010,9(06):407.
　NING Yan song,ZHANG Gong,Surgical management of aortic arch obstruction associated with cardiac anomalies in infants.[J].Journal of Clinical Pediatric Surgery,2010,9(08):407.
[2]杜朝峻,丁力,胡英超,等.手术治疗婴幼儿法洛四联症83例[J].临床小儿外科杂志,2010,9(06):413.
　DU Chao jun,DING Li,HU Ying chao,et al.Surgical treatment of Tetralogy of Fallot in infancy: Experiences of 83 cases.[J].Journal of Clinical Pediatric Surgery,2010,9(08):413.
[3]贾杰,胡祖荣,邓恋,等.瑞芬太尼复合七氟醚在新生儿全身麻醉中的应用[J].临床小儿外科杂志,2010,9(06):464.
[4]郑珊Basnet Anupama黄焱磊陈莲肖现民.新生儿全结肠巨结肠阑尾壁内神经元标记物和神经支配分布的评价[J].临床小儿外科杂志,2011,10(01):0.
　ZHENG Shan,Basnet Anupama,HUANG Yan lei,et al.Evaluation of neuronal markers and innervations distribution in TCA appendix.[J].Journal of Clinical Pediatric Surgery,2011,10(08):0.
[5]江峰赵阳孙莲萍金惠明马杰.婴幼儿阻塞性脑积水两种手术方式的疗效比较[J].临床小儿外科杂志,2011,10(01):0.
　JIANG Feng,ZHAO Yang,SUN Liang ping,et al.Endoscopic third ventricul ostomy versus ventricul operitoneal shunt:clinical study of obstructive hydro cephalus in infants.[J].Journal of Clinical Pediatric Surgery,2011,10(08):0.
[6]马黎明褚衍林乔衍礼武广华李平萍张来住刘宏生程前进李祥张洪宇陈国庆郑善光刘高利安国营孙卓祥董海新.IL-6、TNF-α及sICAM-1在婴幼儿体外循环肺损伤中的表达及超滤干预效果[J].临床小儿外科杂志,2011,10(01):0.
[7]尹鉴淳 徐万华 李守林 王 浩 刘晓东.新生儿先天性重度肾积水诊疗分析[J].临床小儿外科杂志,2010,9(02):0.
[8]陈 快 戴康临 罗 鸣 邓庆强 陶 强 黄金狮.新生儿胃肠穿孔78例诊治分析[J].临床小儿外科杂志,2010,9(02):0.
[9]王鹏高翟波罗淑颖.婴幼儿室间隔缺损合并肺动脉高压的外科治疗[J].临床小儿外科杂志,2010,9(03):0.
[10]陈快戴康临罗鸣邓庆强陶强黄金狮.新生儿胃肠穿孔78例诊治分析[J].临床小儿外科杂志,2010,9(03):0.
[11]邱桐,杨开颖,陈思源,等.普萘洛尔影响婴幼儿血管瘤患儿中枢神经系统功能的新进展[J].临床小儿外科杂志,2019,18(08):646.[doi:10.3969/j.issn.1671-6353.2019.08.006]
　Qiu Tong,Yang Kaiying,Chen Siyuan,et al.Potential effects of propranolol on central nervous system in children with infantile hemangioma[J].Journal of Clinical Pediatric Surgery,2019,18(08):646.[doi:10.3969/j.issn.1671-6353.2019.08.006]

备注/Memo

收稿日期:2018-12-18。
通讯作者:郭晓东,Emali:guoxiaodong@zju.edu.cn

更新日期/Last Update: 1900-01-01